Analyst Insight | November 9, 2017
Eastman Chemical recently announced it had licensed a technology to oxidize 5‑hydroxymethylfurfural (5‑HMF) to 2,5‑furandicarboxylic acid (FDCA) to Origin Materials, which follows Origin’s acquisition of an oxidation plant from Eastman. In light of this announcement, Lux reached out to Origin’s CEO... Not part of subscription
Analyst Insight | March 15, 2018
Lux's Global Biopolymer Outlook 2026: Forecasting Growth in the Next Decade report published in April 2017 described the emerging polyhydroxyalkanoate (PHA) market as one with the potential to satisfy increasing consumer demand for compostable and biodegradable plastics, but requiring significant ... Not part of subscription
by Gihan Hewage
Following its dispute with Avantium, BASF notified Avantium it would be exiting their JV, Synvina, rendering Synvina a wholly owned subsidiary of Avantium. While PEF has stood out in the bio-based polymer space for having improved performance over incumbents for specific applications (such as multilayer plastics replacement), this announcement could prove fatal for its commercialization. Avantium still has strong partnerships throughout its value chain, but BASF was critical in bringing this technology to a commercial scale for both financial contributions and technical expertise in scaling chemical processes. Its absence from the JV provides an opportunity to help scale PEF, despite its recent decrease in momentum.
For the original news article, click here .